KLOW Blend 80mg
An 80mg lyophilised four peptide blend for tissue repair and inflammation research. The combination has not been evaluated in published studies.
Diretório de pesquisaEncontre sua próxima
Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Registro de pesquisa Guia Guia Guia Guia Guia Guia Guia Guia Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Área de pesquisa Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias Notícias
Encontre sua próxima
referência de pesquisa.
Busque nomes de peptídeos, temas de pesquisa, guias e as últimas notícias em um só lugar. Alguns textos pesquisados ainda estão em inglês.
131 resultados em todo o site
Tirzepatide 50mg
A 50mg lyophilised synthetic peptide acting on GIP and glucagon like peptide 1 receptors. Supplied in a single vial for research, not as a licensed medicine.
Cagrilintide 10mg
A 10mg lyophilised synthetic amylin analogue studied in Phase 3 trials with semaglutide. Supplied in a single vial for research use only.
MOTS-c 40mg
A 40mg lyophilised mitochondrial peptide studied mainly in mice and cell models for metabolism, insulin sensitivity and exercise capacity.
5-Amino-1MQ 5mg
A 5mg small molecule NNMT inhibitor studied in cells and mice. Supplied for research, with no published human clinical trials.
PT-141 10mg
A 10mg lyophilised synthetic cyclic heptapeptide activating melanocortin receptors, mainly MC4R. Supplied for research, not as a licensed medicine.
TB-500 10mg
A 10mg lyophilised synthetic peptide corresponding to a region of thymosin beta 4. Studied in cell and animal models, with no human trials for this peptide.
Bacteriostatic Water 10ml
Sterile water containing 0.9% benzyl alcohol, supplied in a 10ml vial for reconstituting lyophilised peptides and other compounds.
BB20 Blend 20mg
A lyophilised blend containing 10mg BPC-157 and 10mg TB-500. The combination itself has not been evaluated in published studies.
Mazdutide 5mg
A 5mg lyophilised oxyntomodulin analogue acting on GLP-1 and glucagon receptors. Supplied for research, not as a licensed medicine.
Thymosin Alpha-1 5mg
A 5mg lyophilised 28 amino acid peptide studied in immune response regulation, particularly T cell function. Supplied for research, not as a licensed medicine.
Eloralintide
An investigational weekly amylin receptor agonist with Phase 1/2 weight management findings and a Phase 3 programme spanning obesity, type 2 diabetes, sleep apnoea and knee osteoarthritis.
Acetyl Tetrapeptide-15
A review reports supplier sponsored sensory neuron experiments and a 20 participant split face, single blind topical study using a capsaicin discomfort endpoint.
Palmitoyl Pentapeptide-4 / Palmitoyl Pentapeptide-3
A 2005 double blind split face moisturizer study and a 2023 21 participant randomized topical study reported exploratory cosmetic signals.
Palmitoyl Tetrapeptide-7/3
Research is cosmetic/cosmeceutical, including cell assays, patents, and formulation testing.
Dipeptide-2
Located literature is chemical, computational, or supplier generated.
Hexapeptide-3
Human evidence located consists of small finished formulation studies, including a 24 participant 60 day study of acetyl hexapeptide 3 containing formulations.
Tripeptide-1 / Copper Peptide
Copper binding tripeptide research examines extracellular matrix signalling, fibroblast responses and topical formulation properties. The free peptide and copper complex have distinct identities.
Felypressin Acetate
Research largely concerns felypressin as the vasoconstrictor component of prilocaine with felypressin local anesthetic products, especially dental or cervical procedures.
Ganirelix Acetate
Controlled ovarian stimulation studies evaluated ganirelix for prevention of premature LH surges.
Thymosin β4 (1–4)
A short thymosin beta 4 fragment listed in tissue biology research. Evidence for full length thymosin beta 4 should be distinguished from evidence for this four residue fragment.
Pasireotide
It has phase II/III research in Cushing’s disease and acromegaly and distinct investigations in neuroendocrine tumors and perioperative pancreatic settings.
Antide / Vapreotide Acetate
Vapreotide has historical research in variceal bleeding and other gastrointestinal/endocrine contexts; Antide research is separate and mainly preclinical.
Aviptadil
Human research includes an exploratory 20 participant pulmonary hypertension study and COVID-19 respiratory failure trials.
Vapreotide Acetate
The principal clinical research context was acute portal hypertension related oesophageal variceal bleeding.
Carperitide
Human research is concentrated in acute heart failure in Japan.
Enfuvirtide
It was developed for treatment experienced HIV-1 infection; TORO studies found improved short term virologic response when added to optimized background therapy, with resistance associated gp41 substitutions documented.
Etelcalcetide
Its primary clinical context is secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis.
Eptifibatide
Large acute coronary syndrome and PCI research includes PURSUIT, in which eptifibatide reduced the 30 day composite of death or nonfatal MI but increased bleeding.
Selank
Small comparative Russian studies in anxiety/neurasthenia and phobic anxiety and somatoform disorders have been published, alongside animal, receptor, and gene expression work.
Amunine
Direct evidence is older endocrine physiology and biochemical purification work, including 1982 pituitary cell and dog studies.
Tesamorelin
A GHRH analogue with randomised evidence of reduced visceral abdominal fat in adults with HIV associated lipodystrophy; defined finished products are authorised for that specific context, not general weight loss.
Histrelin Acetate
FDA labeling and registered studies support long acting subcutaneous histrelin implants for central precocious puberty and advanced prostate cancer contexts.
Opiorphin
Research is biochemical, ex vivo, and rodent analgesia work.
Ipamorelin
Research includes pituitary cell, rat, and swine pharmacology and a registered human postoperative gastrointestinal function study.
Carbetocin Acetate
Research mainly concerns prevention of postpartum haemorrhage.
Tetracosactide Acetate
Its established context is regulated adrenal reserve diagnostic stimulation.
Desmopressin Acetate
Research includes peptide delivery and stability studies and established clinical pharmacology in central diabetes insipidus and selected hemostasis related conditions.
Icatibant Acetate
The strongest research is acute hereditary angioedema (HAE).
Lanreotide
Clinical research includes acromegaly, carcinoid syndrome, and somatostatin receptor positive enteropancreatic neuroendocrine tumors.
Cilengitide
It was developed as an investigational anticancer agent, principally in glioblastoma.
Sermorelin
Research concerns GH stimulation testing and historical pediatric growth failure treatment.
Melanotan-II / MT2
Human evidence is very small and early: a three participant phase I pilot reported pigmentation and adverse effects, and a 20 participant erectile dysfunction study reported responses with frequent nausea/yawning.
Edotreotide
The authorized clinical context is gallium 68 radiolabelling for PET imaging of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours.
Pramlintide Acetate
It has extensive human diabetes research as adjunct to insulin in type 1 and type 2 diabetes, with gastrointestinal adverse effects and clinically important hypoglycemia risk in the treatment setting.
Thymosin Beta-4
Research includes cell and animal injury models and early human studies.
Secretin Acetate
The strongest human context is diagnostic stimulation of pancreatic secretion and gastrin release.
Terlipressin Acetate
Clinical research principally concerns hepatorenal syndrome with rapidly declining kidney function in advanced cirrhosis and related portal/hemodynamic contexts.
Ziconotide
It was developed as a non opioid analgesic with clinical trials in severe chronic pain.
CJC-1295 Without DAC / MOD GRF 1–29
The best known human pharmacology study assessed DAC CJC-1295 in healthy adults.
GLP-1 (7–37)
It is primarily a native peptide research tool and physiologic reference.
Exenatide Acetate
Extensive human research in type 2 diabetes includes randomized studies and extensions of defined drug products.
Lixisenatide Acetate
It has phase III human research in type 2 diabetes, including add on studies with basal insulin and metformin.
Triptorelin Acetate
Human research spans pituitary gonadal axis suppression, central precocious puberty, fertility protocols, and oncology.
Teriparatide Acetate
A PTH(1–34) analogue with strong randomised evidence for reduced vertebral and nonvertebral fractures in specified high risk osteoporosis populations; authorisation applies to defined finished products, not a generic catalogue material.
Alarelin
Research spans animal reproductive biology, veterinary applications, and limited human investigation.
Somatostatin Acetate
It is a mechanistic research reagent for endocrine regulation, gastrointestinal secretion/motility, metabolism, and receptor biology.
Hexarelin
Research predominantly examines short term GH and pituitary responses.
Octreotide Acetate
It has extensive clinical research in acromegaly, secretory syndromes of certain neuroendocrine tumors, and gastroenteropancreatic neuroendocrine tumour research.
Sincalide
Human research uses sincalide as a controlled physiologic/diagnostic stimulus, including cholescintigraphy measurement standardization.
Gonadorelin Acetate
Human research and historical clinical use include endocrine stimulation testing, reproductive endocrinology, and pulsatile treatment of selected hypothalamic GnRH deficiency states.
Leuprorelin Acetate / Leuprolide Acetate
It has extensive clinical and regulatory history in advanced prostate cancer and, depending on formulation and jurisdiction, endometriosis, fibroids, and central precocious puberty.
Goserelin
It is a clinical pharmacology and hormone dependent disease research agent.
Deslorelin
The clearest documented context is veterinary reproductive endocrine research and controlled release implants, with limited human endocrine research.
Buserelin
Historical human research spans IVF protocols, endometriosis, hormone sensitive oncology, and pediatric endocrinology.
GHRP-2
Human research has largely examined acute endocrine pharmacology, GH stimulation/testing, pharmacokinetics, and appetite biology.
GHRP-6
Research is mainly experimental endocrine pharmacology, receptor biology, pharmacokinetics, and preclinical tissue protection work.
Linaclotide
A guanylate cyclase C agonist with a defined GC-C/cGMP mechanism and randomised trial evidence in specified constipation related disorders; authorised uses depend on the finished product, population and jurisdiction.
Larazotide Acetate
The main human research context is celiac disease.
BPC-157
Research is dominated by animal and laboratory soft tissue, gastrointestinal, tendon, ligament, and muscle injury models.
Elamipretide
A mitochondria targeting tetrapeptide with accelerated FDA approval for a defined Barth syndrome strength endpoint; broader mitochondrial myopathy and heart failure programmes remain investigational or have not met key endpoints.
PE 22–28 Acetate
Research comprises recombinant channel assays, neuronal studies, and mouse behavioral/neurogenesis experiments.
ARA-290 / Cibinetide
An investigational erythropoietin derived peptide with small early phase studies in sarcoidosis associated small fiber neuropathy, diabetic macular oedema and metabolic contexts; no authorised indication has been identified.
(5-Leucine)Enkephalin
Research concerns opioid physiology, pain, stress, receptor pharmacology, analytical standards, animal models, and modified analogues/prodrugs.
LL-37
An investigational human cathelicidin studied in topical venous leg ulcer trials and exploratory biomarker work; its broad antimicrobial, immune, regenerative and oncology research remains largely preclinical.
Abaloparatide
A parathyroid hormone related peptide analogue with Phase 3 osteoporosis evidence for fewer new vertebral and nonvertebral fractures and increased bone mineral density in postmenopausal women.
Dermorphin
Evidence is principally preclinical pharmacology and rodent analgesia.
IRGD
Research includes cell systems, spheroids, nanoparticles, imaging constructs, animal cancer models, and early human studies of related development compounds.
Nafarelin
Research spans endometriosis, central precocious puberty, assisted reproduction, fibroids, and other pituitary gonadal axis contexts.
HGH Fragment 177–191
Evidence is largely rodent, isolated adipose tissue, and mechanistic research concerning lipid metabolism.
OGP
Osteogenic growth peptide research concerns bone, osteoblast, fracture healing, and hematopoietic models.
MOG (35–55)
It is an experimental antigen used to induce or study experimental autoimmune encephalomyelitis in susceptible rodents.
Lixisenatide
Clinical research is primarily in type 2 diabetes.
Beta-Neoendorphin
It is principally a biochemical and preclinical research model.
Dynorphin A (1–17)
Research concerns opioid signaling, pain and stress biology, neuroinflammation, addiction related processes, and inflammatory/cardiovascular models.
Beta-Endorphin
Research examines pain, stress/reward, neuroendocrine signaling, and associations with neurological/psychiatric conditions.
Epithalon
Evidence is predominantly cell, animal, and in silico research.
Semax Acetate
Research focuses on neuroprotection, stroke recovery, neurotrophin related signaling, and brain network effects.
Arg(34)GLP-1 (7–37)
The unacylated item mainly appears as a research intermediate, comparator, or building block in GLP-1 analogue design.
C-Peptide
Human use is mainly measurement for diabetes classification, endogenous insulin assessment, and beta cell function trials.
Retatrutide
An investigational triple hormone receptor agonist in Phase 3 trials spanning obesity, type 2 diabetes and obesity related conditions including sleep apnoea and knee osteoarthritis.
Semaglutide
A GLP-1 receptor agonist supported by major randomised programmes in type 2 diabetes, chronic weight management and cardiovascular outcomes; authorisation depends on the named finished product, formulation, dose and indication.
Oligopeptide P11-4
A self assembling peptide studied in professional topical dental formulations for early, non cavitated caries; randomised evidence concerns lesion size and caries inactivation outcomes, not established cavities or generic peptide material.
CBL-514
An investigational small molecule injection studied in early Phase II/IIa programmes for localized abdominal subcutaneous fat and cellulite; it is not an authorised medicine and other development areas remain exploratory.
NAD+
Nicotinamide adenine dinucleotide is a cellular coenzyme studied in redox reactions, energy metabolism and signalling. It is a small molecule cofactor rather than a peptide.
Glow GHK-CU Blend
Copper peptide evidence is mainly mechanistic, cell, animal, topical and cosmetic, and review level.
Why China matters in biotechnology research
China's research investment, biotechnology sector and clinical research infrastructure.
Longevity and peptide research
Ageing biology, peptide mechanisms and how to interpret longevity research.
How to read peptide clinical research
Clinical trials, study design, endpoints and evidence levels.
How to read a peptide COA
Certificates of analysis, HPLC purity, molecular identity and batch documentation.
Peptide traceability
Supplier, batch, analytical test and documentation traceability.
Peptide questions and answers
Peptide identity, UK research enquiries, Retatrutide and common questions.
About OrientSciences
Our UK and Switzerland based team and manufacturer relationships in China.
Contact OrientSciences
Contact the team about research materials, documents and quotations.
Metabolic Research
Explore incretin, amylin and metabolic peptide research, including Retatrutide, Semaglutide and native signalling peptides. Records explain molecule identity, study context and available evidence.
Neuroscience Research
Explore neuropeptide signalling, receptor pharmacology and experimental neuroscience. This collection brings together endogenous peptides and investigational compounds with distinct evidence profiles.
Reproductive & Endocrine Research
Explore peptides studied in pituitary and reproductive endocrine signalling. Records cover hormone analogues, receptor antagonists and their documented research contexts.
Growth Hormone & Endocrine Research
Explore growth hormone releasing peptides and endocrine research tools, including Sermorelin, Tesamorelin and CJC-1295 variants. Each record distinguishes the named material from related analogues.
Dermal & Formulation Science
Explore peptides used in skin, cosmetic formulation and dental materials research. Evidence varies between isolated molecules and finished formulations, so each record identifies the relevant study context.
Cardiovascular & Vascular Research
Explore peptides studied in vascular signalling, cardiovascular physiology and haemodynamic research. Read the evidence context and molecular identity for each record.
Gastrointestinal & Peptide Biology
Explore gastrointestinal peptide biology, secretion and receptor signalling. Records include native peptides, analogues and defined clinical reference molecules.
Tissue & Regenerative Biology
Explore peptides studied in cellular responses, mitochondrial biology and tissue models, including Elamipretide, LL-37 and Thymosin Beta-4. Each record explains the level and scope of the evidence.
Skeletal & Mineral Biology
Explore peptide research in bone turnover, osteoblast biology and mineral regulation. Records distinguish evidence for defined clinical products from the research materials listed in the catalogue.
Specialist & Translational Research
Explore specialist peptide and cofactor research spanning imaging, oncology models and translational biology. Each record provides an entry point to molecular identity and supporting research context.
Peptide news this week: Australia clears an oral semaglutide tablet, and AI sequencing tools meet their limits
Australia's TGA registers oral Wegovy, the first oral GLP-1 cleared there, and a Nature Methods benchmark shows where AI peptide sequencing still fails.
A lipid-tailed ring peptide blocks SARS-CoV-2 fusion by locking the spike in place
S-880008, a ring peptide with a lipid chain, locks the SARS-CoV-2 spike and blocks fusion, and cut viral load in mice, Shionogi and Hokkaido University report.
Chemists make stapled peptides that switch on and off with light, and stay switched for weeks
A new light-sensitive brace, azobispyrazole, lets stapled peptides be flipped into a tighter-binding shape with light and back again, McCann, Prischich et al. report.
A small brain peptide, T30, raised amyloid and tau when infused into rat brains
A UK team infused T30, a peptide taken from acetylcholinesterase, into rat brains and found more amyloid beta and phosphorylated tau, reported in Neurochemical Research.
A short peptide frees SIRT1, an ageing-linked enzyme, and eases senescence in lab cells
A peptide called pSirt1-4 breaks the link between USP25 and SIRT1 and eased signs of senescence in lab cells, a Tongji University team reports in Aging Cell.
A fruit fly sleep protein makes peptides that jam up bacteria from the inside
Peptides cut from the fly sleep protein Nemuri clump bacterial ribosomes and stall protein production, including in MRSA and VRE, in lab tests.
A scorpion venom peptide held back two very different viruses in lab tests
BmKDfsin3, a scorpion venom peptide, slowed the tick-borne SFTS virus and the cold sore virus HSV-1 in human lung cells, a Wuhan team reports.
Two peptide studies this week: clearing old gut cells in flies, and better sleep in Alzheimer's mice
A fruit fly peptide called pileup seems to help clear worn-out gut cells, and neuropeptide S improved sleep and cut amyloid in Alzheimer's model mice.
Roche pays Hansoh $400 million upfront in a cancer drug deal worth more than $15 billion
Roche has paid Hansoh $400 million upfront for cancer ADC programmes, with milestones that could take the deal past $15 billion.
China's stem cell therapy for Parkinson's: inside XS411 and the trials the West is overlooking
Four Chinese stem cell therapies for Parkinson's are in human trials. XS411 added five hours of good ON time a day in phase I, and phase II is fully enrolled.
How China became a leading force in medical science: cancer, CAR-T and beyond
China now leads in high quality cancer papers and new oncology drug approvals. A look at its CAR-T, oncolytic virus, stroke and public health breakthroughs.
A busy week for peptide research: new antimicrobials and a longer lasting teriparatide
Three new peptide studies: AI designed lipopeptides, a frog derived peptide against resistant Acinetobacter, and a more stable teriparatide.
Peptide research this week: oral therapies and new trial results
Five developments in peptide research, from oral therapies and phase 3 trials to cancer delivery and peptide chemistry. Updated 15 October 2026.
A China led phase 2 study of the triple agonist UBT251 is published
A 7 October Cell Metabolism report describes a multicentre phase 2 study of investigational UBT251, which targets GLP-1, GIP and glucagon receptors.
A cell penetrating partner improves an antimicrobial peptide in preclinical models
Researchers at the Chinese Academy of Sciences reported a Bac7-HC1 peptide conjugate that outperformed other tested combinations in laboratory and mouse infection models.
A Macao team releases a large peptide protein interaction resource
PPIKB brings together measured peptide binding data and experimentally resolved protein peptide structures for researchers working on peptide discovery and modelling.
How to use the OrientSciences research catalogue
A short guide to reading a research record, following cited sources and using this weekly news feature to find newly published peptide and China biotech research.